Excellthera Is A Clinical Stage Biotechnology Company Focused On Advanced Cell Expansion And Rejuvenation Technologiesfounded In June 2015It Emerged From Ccrm And The Institute For Research In Immunology And Cancer Commercialization Of Researchiricor The Company Develops Innovative Solutions For Blood Stem Cell Transplantation And Gene Therapyutilizing Its Proprietary Enhancea C Platform To Improve Stem Cell Yield And Metabolic Fitness The Enhancea C Platform Combines Um171A Small Molecule Agonistwith Optimized Culture Conditions To Expand Hematopoietic Stem Cellshscsex Vivothis Technology Enhances Cell Dose And Quality While Reducing Stress From Gene Editing Or Prolonged Cultureexcellthera Is Also Advancing Um171 Cell Therapydorocubicel Which Targets High Risk Hematological Malignancies And Is Being Explored For Various Blood Disordersthe Company Collaborates With Biopharmaceutical Firms To Integrate Its Technologies Into Cell And Gene Therapy Developmentproviding Scalable Manufacturing Solutionsexcellthera Aims To Improve Patient Outcomes In Hematological Diseases By Addressing Challenges In Stem Cell Availability And Compatibility
United States
